Verastem Latest News
- 02-20 AInvest WireVerastem Oncology Announces Multiple Presentations at Society of Gynecologic Oncology 2025 Annual Meeting
- 02-14 AInvest WireBalyasny Asset Management Acquires Verastem Inc, Diversifying Biotech Portfolio
- 02-12 AInvest WireVestrum Blockchain Ecosystem: A Long-Term Financial Growth Solution
- 02-05 AInvest NewsInsider Transactions Reported | Verastem(VSTM)saw insider trading activity on 2/5/2025
- 02-05 AInvest WireVerastem CEO Paterson Dan Sells 858 Shares at $5.7 Each on 2023-02-04.
- 02-05 AInvest WireVerastem shares fall 1.52% premarket after B. Riley adjusts price target.
- 02-03 AInvest WireVerastem shares fall 3.78% premarket after B. Riley adjusts price target.
- 01-31 AInvest NewsVerastem: B. Riley Securities maintains a 'Buy' Rating, The Target Price is $9
- 01-31 AInvest WireVerastem: B. Riley Securities raises Buy rating, PT to $9 from $7.
- 01-31 MarketWatchVerastem price target raised to $9 from $7 at B. Riley
- 01-30 AInvest WireVerastem shares fall 5.79% after-hour following NDA submission denial.
- 01-28 AInvest WireVerastem shares up 1.72% after-hours following NDA submission completion.
- 01-28 AInvest WireVerastem's 15min chart shows a KDJ Golden Cross, indicating a bullish trend with a Bullish Marubozu.
- 01-28 AInvest WireVerastem's KDJ Death Cross and Bearish Marubozu Signal Potential Decline.
- 01-27 AInvestVerastem's 15min chart shows Bollinger Bands narrowing, KDJ death cross formation.
- 01-27 AInvest WireVerastem's 15min chart shows Bollinger Bands expanding downward and KDJ death cross.
- 01-24 AInvest NewsVerastem: Guggenheim reiterates the 'Buy' Rating
- 01-24 AInvest WireVerastem shares up 1.79% intraday after strategic priorities announcement.
- 01-24 AInvest WireVerastem: Guggenheim Reiterates Buy Rating, No Change in Recommendation
- 01-24 MarketWatchMizuho Securities Sticks to Its Buy Rating for Verastem (VSTM)
Show More News
